Slowing Biological Aging May Be GLP-1 Drugs' Next Medical Frontier

Recent research is uncovering how GLP-1 drugs, traditionally used for managing diabetes, might hold the key to slowing down biological aging. By examining DNA-based age markers in people living with HIV, scientists are gaining insights into how these medications could affect the molecular clocks that dictate aging. This discovery could revolutionize the way we approach age-related diseases, offering hope for treatments that extend healthy lifespan. The implications are huge, potentially reshaping our understanding of aging and the development of new therapies.